Eli Lilly: appoints Thomas J. Fuchs as head of AI

(CercleFinance.com) - Eli Lilly announces the appointment of Thomas J.
Fuchs, Dr.sc., as its first Head of AI, effective October 21, 2024.

In this role, he will lead the company's artificial intelligence (AI) initiatives, covering drug discovery, clinical trials, manufacturing and other internal functions.

Prior to joining the lab, Thomas J. Fuchs was Dean and Head of AI and Human Health at Mount Sinai and has held various positions at prestigious institutions.

Copyright (c) 2024 CercleFinance.com. All rights reserved.